United States · FDA National Drug Code directory

METOPROLOL SUCCINATE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69097-407_95bb3551-0e88-47cc-95e9-35c6dc731faf
Product NDC: 69097-407
Form: TABLET, EXTENDED RELEASE
Composition / generic term: metoprolol succinate
Labeler: Cipla USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20190325
Source listing expiry: 20261231

Source-listed ingredients

METOPROLOL SUCCINATE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-407-02) · 69097-407-02
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-407-07) · 69097-407-07
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-407-15) · 69097-407-15

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →